BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 238 filers reported holding BLUEBIRD BIO INC in Q1 2021. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395 | +6.2% | 130,097 | +15.0% | 0.00% | +33.3% |
| Q2 2023 | $372 | -85.2% | 113,093 | -68.8% | 0.00% | -91.4% |
| Q4 2022 | $2,508 | -99.9% | 362,544 | -54.6% | 0.04% | -2.8% |
| Q2 2022 | $3,303,000 | +486.7% | 798,048 | +4170.6% | 0.04% | +500.0% |
| Q1 2021 | $563,000 | +17.8% | 18,687 | +396.3% | 0.01% | -80.0% |
| Q2 2019 | $478,000 | +46.2% | 3,765 | +81.0% | 0.03% | -41.2% |
| Q1 2019 | $327,000 | – | 2,080 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |